Malin Corporation | MLC - Creditori Commerciali

Prezzo Delle Azioni
7.45
Cambio Giornaliero
-0.15 -1.97%
Mensile
-6.88%
Annuale
-12.35%
Q2 Previsione
7.23




Creditori Commerciali Cambiamento Data
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alaunos Therapeutics USD 400K 213K 2026-03
ALKERMES USD 102.36M 5.59M 2026-03
Avita Medical AUD 8.96M 1.69M 2025-12
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Eurofins Scientific SE EUR 678M 72.7M 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
IQVIA Holdings USD 3.64B 112M 2026-03
Lonza CHF 471M 3M 2024-12
Malin Corporation EUR 700K 200K 2024-12
Moderna USD 161M 156M 2026-03
Organon & Co USD 983M 31M 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Revvity USD 169.68M 15.78M 2026-03
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Viatris USD 1.2B 93.9M 2026-03
Xeris Pharmaceuticals USD 11.47M 8.39M 2026-03